- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterOncoLink at ASCO 1996: Sunday, May 19
Photo (l to r): R. Judith Radzan, MD, Peter Cassileth, MD, Miami, Florida, USA
|
National Cancer Insitute Director's Address
Note: Dr. Richard Klausner, Director of the National Cancer Institute since August 1995, was today inducted into the membership of ASCO by Dr. John Glick, outgoing president of ASCO. He addressed a packed Exhibit Hall in Philadelphia's Convention... |
|
|
New Discoveries in Treating Women's Cancer Reported at ASCO Meeting
Philadelphia, PA, May 20, 1996 -- Exciting new discoveries in the treatment of ovarian and breast cancer were reported today at the 32nd Annual Meeting of the American Society of Clinical Oncology (ASCO). Ovarian Cancer is the second most common... |
|
|
Optimal Timing of Breast Cancer Surgery Within Menstrual Cycle
Mark Norman Levine, M.D., Ontario Cancer Foundation, Hamilton University and professor of medicine, McMaster University, National Cancer Institute of Canada Clinical Trials Group (Kingston, Ontario, Canada), presented a study which examined the... |
|
|
Phase I Study Results for Pegylated Megakaryocyte Growth And Development Factor, A New Platelet Growth Factor
Results of the first trial of pegylated megakaryocyte growth and development factor (PEG_rHuMGDF), a novel platelet growth factor, in human beings were presented at the ASCO Annual Meeting by Michael Fanucchi, M.D., associate professor of medicine,... |
|
|
Phase I Study Results for Thrombopoietin, A New Cytokine
Saroj Vadhan-Raj, M.D., associate professor and director, Regulation of Hematopoiesis, Bioimmunotherapy Department, M.D. Anderson Cancer Center (Houston, Texas), presented interim results of two Phase I studies of single-dose recombinant human... |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
